Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 14.17 USD 3.13% Market Closed
Market Cap: 391.1m USD
Have any thoughts about
ZimVie Inc?
Write Note

ZimVie Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ZimVie Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Z
ZimVie Inc
NASDAQ:ZIMV
Income from Continuing Operations
-$56m
CAGR 3-Years
32%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
14%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.3B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
No Stocks Found

ZimVie Inc
Glance View

Market Cap
390.9m USD
Industry
Health Care

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

ZIMV Intrinsic Value
17.8 USD
Undervaluation 20%
Intrinsic Value
Price
Z

See Also

What is ZimVie Inc's Income from Continuing Operations?
Income from Continuing Operations
-56m USD

Based on the financial report for Dec 31, 2023, ZimVie Inc's Income from Continuing Operations amounts to -56m USD.

What is ZimVie Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
34%

Over the last year, the Income from Continuing Operations growth was 12%. The average annual Income from Continuing Operations growth rates for ZimVie Inc have been 32% over the past three years , 34% over the past five years .

Back to Top